Source comparison
Comparison: BPC-157 Administration Methods for Bone Healing
Subcutaneous (near injury) 60–70% 30–90 minutes High (first-pass local uptake) Low (shallow, minimal pain) Optimal for bone healing. Balances systemic absorption with localised tissue concentration without inflammation Subcutaneous (distant site) Low (systemic
This comparison does not assign a generated winner or score.
- Subcutaneous (near injury)
- 60–70%
- 30–90 minutes
- High (first-pass local uptake)
- Low (shallow, minimal pain)
- Optimal for bone healing. Balances systemic absorption with localised tissue concentration without inflammation
- Subcutaneous (distant site)
- Low (systemic distribution only)
- Low
- Effective for systemic healing but loses site-specific advantage. Use when injury site is inaccessible
- Intramuscular
- 80–85%
- 20–60 minutes
- Moderate
- Moderate (deeper, more painful)
- Higher bioavailability but increased inflammation at injection site. Reserve for non-acute cases
- Oral (not recommended)
- <10%
- N/A (degraded by pepsin)
- Negligible
- None
- Gastric acid and proteolytic enzymes destroy the peptide before absorption. Ineffective for bone healing